Skip to main content
. 2023 Jun 5;6(3):e000540. doi: 10.1136/wjps-2022-000540

Table 4.

Survival analysis considering Down syndrome and congenital heart disease as risk factors in each group of anomaly

Disease group Survival at 1 year P value* Survival at 1 year P value
HR (95% CI) HR (95% CI)
ESO Without DS 86.56% 0.941 Without CHD 90.15% 0.004
With DS 85.71% 0.93 (0.12 to 6.81) With CHD 78.32% 2.72 (1.34 to 5.52)
CDO Without DS 94.25% 0.122 Without CHD 94.32% 0.004
With DS 85.10% 2.31 (0.77 to 6.92) With CHD 80.48% 4.42 (1.48 to 13.19)
INTES Without DS 92.64% 0.245 Without CHD 92.61% 0.299
With DS 80.00% 3.23 (0.40 to 26.31) With CHD 83.33% 2.89 (0.35 to 23.49)
HSCR Without DS 97.01% <0.001 Without CHD 96.67% <0.001
With DS 74.47% 7.57 (4.12 to 13.91) With CHD 75.78% 5.82 (2.85 to 11.92)
5.55 (2.63 to 11.75)† 2.11 (0.88 to 5.10)†
ARM Without DS 93.27% 0.595 Without CHD 95.68% <0.001
With DS 92.19% 1.24 (0.56 to 2.78) With CHD 81.89% 4.57 (2.55 to 8.21)
OMP Without DS 90.29% 0.726 Without CHD 92.56% 0.026
With DS 100.00% NA With CHD 77.78% 4.68 (1.05 to 20.93)
GAS Without DS 93.44% NA Without CHD 92.43% 0.612
With DS NA NA With CHD 100.00% NA
CDH Without DS 91.92% 0.006 Without CHD 96.66% <0.001
With DS 50.00% 10.83 (1.29 to 90.64) With CHD 66.67% 12.97 (2.51 to 66.98)
19.90 (1.66 to 239.23)† 15.49 (2.75 to 87.08)†
Overall Without DS 94.31% <0.001 Without CHD 95.32% <0.001
With DS 84.92% 2.54 (1.72 to 3.76) With CHD 78.80% 4.93 (3.60 to 6.76)
1.34 (0.87 to 2.04)† 4.53 (3.21 to 6.37)†

*P value of log-rank test.

†Adjusted HR.

ARM, anorectal malformation; CDH, congenital diaphragmatic hernia; CDO, congenital duodenal obstruction; CHD, congenital heart disease; CI, confidence interval; DS, Down syndrome; ESO, esophageal malformation; GAS, gastroschisis; HR, hazard ratio; HSCR, Hirschsprung’s disease; INTES, jejunoileal atresia; NA, not analyzed; OMP, omphalocele.